Earnings Feed
Start Free
Home/Insiders/Stewart Robert A
SR
SEC Insider//CIK 0001476493

Stewart Robert A

CIK 00014764934 companiesPARSIPPANY, NJ
SEC Profile

Transactions

50

Companies

4

Filings

14

CIK

0001476493

Recent Transactions

50 trades
  • Award
    CorMedix Inc.$CRMD

    Common Stock

    2026-01-26+30,453→ 66,453 total
  • Award
    CorMedix Inc.$CRMD

    Common Stock

    2025-01-17+25,000→ 36,000 total
  • Award
    CorMedix Inc.$CRMD

    Stock Option (Right to Buy Common Stock)

    2024-03-05+30,000→ 30,000 total
  • Purchase
    CorMedix Inc.$CRMD

    Common Stock

    2023-05-17$4.37/sh+10,000→ 11,000 total
  • Award
    CorMedix Inc.$CRMD

    Common Stock

    2023-05-17$4.37/sh+10,000→ 11,000 total
  • Award
    CorMedix Inc.$CRMD

    Stock Option (Right to Buy Common Stock)

    2023-04-13+25,000→ 25,000 total
  • Award
    CorMedix Inc.$CRMD

    Stock Option (Right to Buy Common Stock)

    2023-04-13+14,200→ 14,200 total
  • Tax Payment
    Amneal Pharmaceuticals, Inc.$AMRX

    Class A Common Stock

    2019-05-07$13.44/sh−21,609→ 78,668 total
  • Exercise/Conversion
    Amneal Pharmaceuticals, Inc.$AMRX

    Restricted Stock Units

    2019-05-07−83,277→ 249,834 total
  • Exercise/Conversion
    Amneal Pharmaceuticals, Inc.$AMRX

    Class A Common Stock

    2019-05-07+83,277→ 100,277 total
  • Purchase
    Amneal Pharmaceuticals, Inc.$AMRX

    Class A Common Stock

    2019-03-12$11.92/sh+17,000→ 17,000 total
  • Award
    Amneal Pharmaceuticals, Inc.$AMRX

    Stock Option

    2019-03-01+402,212→ 402,212 total
  • Award
    Amneal Pharmaceuticals, Inc.$AMRX

    Restricted Stock Units

    2019-03-01+197,531→ 197,531 total
  • Award
    Amneal Pharmaceuticals, Inc.$AMRX

    Restricted Stock Units

    2018-05-07+333,111→ 333,111 total
  • Award
    Amneal Pharmaceuticals, Inc.$AMRX

    Stock Option

    2018-05-07+681,199→ 681,199 total
  • Tax Payment
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-12-29$163.58/sh−2,149→ 66,650 total
  • Exercise/Conversion
    Allergan plc

    Performance Based Restricted Share Unit

    2017-10-26−12,427→ 0 total
  • Exercise/Conversion
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-10-26+12,427→ 68,799 total
  • Award
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-04-03$237.68/sh+7,362→ 56,372 total
  • Tax Payment
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-03-05$245.63/sh−761→ 49,010 total
  • Conversion
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-02-01+2,369→ 0 total
  • Award
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-02-01$229.32/sh+2,369→ 50,569 total
  • Tax Payment
    Allergan plc

    Ordinary Shares, par value $0.0001

    2017-02-01$229.32/sh−798→ 49,771 total
  • Tax Payment
    Allergan plc

    Ordinary Shares, par value $0.0001

    2015-03-05$295.70/sh−411→ 44,225 total
  • Tax Payment
    Allergan plc

    Ordinary Shares, par value $0.0001

    2015-03-05$295.70/sh−593→ 48,200 total
  • Award
    Allergan plc

    Ordinary Shares, par value $0.0001

    2015-03-05+4,568→ 48,793 total
  • Award
    Allergan plc

    Performance-Based Restricted Stock Unit

    2014-07-01+28,245→ 28,245 total
  • Award
    Allergan plc

    Stock Option (Right to Buy)

    2014-07-01+25,704→ 25,704 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-12-09$166.02/sh−8,000→ 41,253 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-11-15$164.44/sh−10,000→ 49,253 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-11-11$158.39/sh−12,000→ 59,252 total
  • Award
    Allergan plc

    Ordinary Shares

    2013-10-01+71,252→ 71,252 total
  • Disposition to Issuer
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-10-01−71,252→ 0 total
  • Disposition to Issuer
    Allergan Finance LLC

    Stock Option (Right to Buy)

    2013-09-30−75,000→ 0 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30+44,312→ 193,203 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30$86.86/sh+75,000→ 148,891 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30$144.00/sh−121,951→ 71,252 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-08-02$136.02/sh−14,564→ 73,891 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-08-02$136.02/sh−14,564→ 73,891 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-06+8,844→ 81,164 total
  • Award
    Allergan Finance LLC

    Stock Options to Purchase Common Stock

    2013-03-06+75,000→ 75,000 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-06+7,291→ 88,455 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-02$85.54/sh−4,834→ 72,320 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-10-31+14,543→ 77,154 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-08+8,553→ 62,611 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-08+10,955→ 54,058 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-02-24$58.17/sh−1,640→ 43,103 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-11-16$64.52/sh−1,622→ 44,743 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-03-02+14,365→ 46,365 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-02-24+10,000→ 32,000 total

Companies

4

Recent Filings

14

Address

C/O CORMEDIX INC. 389 INTERPACE PKWY, SUITE 450

PARSIPPANY, NJ, 07054

View on SEC.gov